Biovara stands at the intersection of medical need and market potential. As the only company focused exclusively on developing a treatment for lung cancer cough, our opportunity is both urgent and unique.

Backed by published data, an experienced leadership team, and early clinical signals of efficacy, having completed Phase I development, Biovara is at the stage of planning its proof of concept patient study.